Toward the promise of microRNAs – Enhancing reproducibility and rigor in microRNA research

RNA Biology

Volumn 13, Issue 11, 2016, Pages 1103-1116

  Witwer, Kenneth W ^a   Halushka, Marc K ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; microRNA; miRNA; small RNA seq; transfection; translational research; xenomir

Indexed keywords

MICRORNA;

GENE CONTROL; INTERACTIONS WITH RNA; NONHUMAN; REVIEW; RNA ANALYSIS; RNA SEQUENCE; RNA SYNTHESIS; RNA TRANSLATION; SEQUENCE ALIGNMENT; ANIMAL; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; PROCEDURES; TISSUE DISTRIBUTION; TRANSLATIONAL RESEARCH;

ANIMALS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; TISSUE DISTRIBUTION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84992756728     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.1080/15476286.2016.1236172     Document Type: Review

References (125)

1. X.Gu, J.Y.Li, J.Guo, P.S.Li, W.H.Zhang. Influence of MiR-451 on drug resistances of paclitaxel-resistant breast cancer cell line. Medical Sci Monitor 2015; 21:3291-7; PMID:26516138; http://dx.doi.org/10.12659/MSM.894475
2. Z.Su, J.Zhao, Z.Rong, W.Geng, Z.Wang. MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer. International J Clin Exp Pathol 2015; 8:9154-60; PMID:26464660
3. X.Liu, X.Zhang, J.Xiang, Y.Lv, J.Shi. miR-451:potential role as tumor suppressor of human hepatoma cell growth and invasion. Int J Oncol 2014; 45:739-45; PMID:24841638; http://dx.doi.org/10.3892/ijo.2014.2446
4. S.D.Cai, J.S.Chen, Z.W.Xi, L.J.Zhang, M.L.Niu, Z.Y.Gao. MicroRNA144 inhibits migration and proliferation in rectal cancer by downregulating ROCK1. Mol Med Reports 2015; 12:7396-402; PMID:26458302
5. B.A.Haider, A.S.Baras, M.N.McCall, J.A.Hertel, T.C.Cornish, M.K.Halushka. A critical evaluation of microRNA biomarkers in non-neoplastic disease. PLoS One 2014; 9:e89565; PMID:24586876; http://dx.doi.org/10.1371/journal.pone.0089565
6. S.Wang, A.B.Aurora, B.A.Johnson, X.Qi, J.McAnally, J.A.Hill, J.A.Richardson, R.Bassel-Duby, E.N.Olson. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008; 15:261-71; PMID:18694565; http://dx.doi.org/10.1016/j.devcel.2008.07.002
7. M.N.McCall, O.A.Kent, J.Yu, K.Fox-Talbot, A.L.Zaiman, M.K.Halushka. microRNA profiling of diverse endothelial cell types. BMC Med Genomics 2011; 4:78; PMID:22047531; http://dx.doi.org/10.1186/1755-8794-4-78
8. M.Civelek, R.Hagopian, C.Pan, N.Che, W.P.Yang, P.S.Kayne, N.K.Saleem, H.Cederberg, J.Kuusisto, P.S.Gargalovic, et al. Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits. Hum Mol Genet 2013; 22:3023-37; PMID:23562819; http://dx.doi.org/10.1093/hmg/ddt159
9. R.Feng, X.Chen, Y.Yu, L.Su, B.Yu, J.Li, Q.Cai, M.Yan, B.Liu, Z.Zhu. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Letters 2010; 298:50-63; PMID:20619534; http://dx.doi.org/10.1016/j.canlet.2010.06.004
10. F.Ebrahimi, V.Gopalan, R.Wahab, C.T.Lu, R.A.Smith, A.K.Lam. Deregulation of miR-126 expression in colorectal cancer pathogenesis and its clinical significance. Exp Cell Res 2015; 339:333-41; PMID:26455548; http://dx.doi.org/10.1016/j.yexcr.2015.10.004
11. Z.Yang, R.Wang, T.Zhang, X.Dong. MicroRNA-126 regulates migration and invasion of gastric cancer by targeting CADM1. Int J Clin Exp Pathol 2015; 8:8869-80; PMID:26464628
12. L.Yu, Y.Yang, J.Hou, C.Zhai, Y.Song, Z.Zhang, L.Qiu, X.Jia. MicroRNA-144 affects radiotherapy sensitivity by promoting proliferation, migration and invasion of breast cancer cells. Oncol Rep 2015; 34:1845-52; PMID:26252024; http://dx.doi.org/10.3892/or.2015.4173
13. G.Zhang, H.An, X.Fang. MicroRNA-144 regulates proliferation, invasion, and apoptosis of cells in malignant solitary pulmonary nodule via zinc finger E-box-binding homeobox 1. Int J Clin Exp Pathol 2015; 8:5960-7; PMID:26191328
14. Z.Xu, S.Ramachandran, M.Gunasekaran, F.Zhou, E.Trulock, D.Kreisel, R.Hachem, T.Mohanakumar. MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation. J Heart Lung Transplantation 2015; 34:1154-62; PMID:25979625; http://dx.doi.org/10.1016/j.healun.2015.03.021
15. M.Zhao, J.Huang, K.Gui, M.Xiong, G.Cai, J.Xu, K.Wang, D.Liu, X.Zhang, W.Yin. The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression. Int J Mol Med 2014; 34:1565-72; PMID:25318625; http://dx.doi.org/10.3892/ijmm.2014.1963
16. C.M.Gits, P.F.van Kuijk, M.B.Jonkers, A.W.Boersma, M.Smid, W.F.van Ijcken, J.M.Coindre, F.Chibon, C.Verhoef, R.H.Mathijssen, et al. microRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors. Int J Cancer 2014; 135:348-61; PMID:24375455; http://dx.doi.org/10.1002/ijc.28694
17. H.Zhu, H.Wu, X.Liu, B.R.Evans, D.J.Medina, C.G.Liu, J.M.Yang. Role of microRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 2008; 76:582-8; PMID:18619946; http://dx.doi.org/10.1016/j.bcp.2008.06.007
18. H.Sun, C.Cui, F.Xiao, H.Wang, J.Xu, X.Shi, Y.Yang, Q.Zhang, X.Zheng, X.Yang, et al. miR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targeting CLDN10 and CITRON. Hepatol Res 2015; 45:1312-22; PMID:25655186; http://dx.doi.org/10.1111/hepr.12500
19. W.Pang, X.Tian, F.Bai, R.Han, J.Wang, H.Shen, X.Zhang, Y.Liu, X.Yan, F.Jiang, et al. Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer. Mol Cancer 2014; 13:240; PMID:25342548; http://dx.doi.org/10.1186/1476-4598-13-240
20. O.A.Kent, M.N.McCall, T.C.Cornish, M.K.Halushka. Lessons from miR-143/145:the importance of cell-type localization of miRNAs. Nucleic Acids Res 2014; 42:7528-38; PMID:24875473; http://dx.doi.org/10.1093/nar/gku461
21. C.C.Pritchard, E.Kroh, B.Wood, J.D.Arroyo, K.J.Dougherty, M.M.Miyaji, J.F.Tait, M.Tewari. Blood cell origin of circulating microRNAs:a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 2012; 5:492-7; PMID:22158052; http://dx.doi.org/10.1158/1940-6207.CAPR-11-0370
22. Z.Bian, L.Li, J.Cui, H.Zhang, Y.Liu, C.Y.Zhang, K.Zen. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis. J Pathol 2011; 225:544-53; PMID:21590770; http://dx.doi.org/10.1002/path.2907
23. A.S.Baras, C.J.Mitchell, J.R.Myers, S.Gupta, L.C.Weng, J.M.Ashton, T.C.Cornish, A.Pandey, M.K.Halushka. miRge - A multiplexed method of processing small RNA-Seq data to determine microRNA entropy. PLoS One 2015; 10:e0143066; PMID:26571139; http://dx.doi.org/10.1371/journal.pone.0143066
24. D.M.Vitsios, A.J.Enright. Chimira:analysis of small RNA sequencing data and microRNA modifications. Bioinformatics 2015; 31:3365-7; PMID:26093149; http://dx.doi.org/10.1093/bioinformatics/btv380
25. C.A.Raabe, T.H.Tang, J.Brosius, T.S.Rozhdestvensky. Biases in small RNA deep sequencing data. Nucleic Acids Res 2014; 42:1414-26; PMID:24198247; http://dx.doi.org/10.1093/nar/gkt1021
26. R.T.Fuchs, Z.Sun, F.Zhuang, G.B.Robb. Bias in ligation-based small RNA sequencing library construction is determined by adaptor and RNA structure. PLoS One 2015; 10:e0126049; PMID:25942392; http://dx.doi.org/10.1371/journal.pone.0126049
27. C.Backes, F.Sedaghat-Hamedani, K.Frese, M.Hart, N.Ludwig, B.Meder, E.Meese, A.Keller. Bias in high-throughput analysis of miRNAs and implications for biomarker studies. Analy Chem 2016; 88:2088-95; PMID:26760198; http://dx.doi.org/10.1021/acs.analchem.5b03376
28. O.A.Kent, R.R.Chivukula, M.Mullendore, E.A.Wentzel, G.Feldmann, K.H.Lee, S.Liu, S.D.Leach, A.Maitra, J.T.Mendell. Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev 2010; 24:2754-9; PMID:21159816; http://dx.doi.org/10.1101/gad.1950610
29. R.R.Chivukula, G.Shi, A.Acharya, E.W.Mills, L.R.Zeitels, J.L.Anandam, A.A.Abdelnaby, G.C.Balch, J.C.Mansour, A.C.Yopp, et al. An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration. Cell 2014; 157:1104-16; PMID:24855947; http://dx.doi.org/10.1016/j.cell.2014.03.055
30. Y.Akao, Y.Nakagawa, Y.Kitade, T.Kinoshita, T.Naoe. Downregulation of microRNAs-143 and −145 in B-cell malignancies. Cancer Sci 2007; 98:1914-20; PMID:17892514; http://dx.doi.org/10.1111/j.1349-7006.2007.00618.x
31. X.Huang, T.Yuan, M.Tschannen, Z.Sun, H.Jacob, M.Du, M.Liang, R.L.Dittmar, Y.Liu, M.Liang, et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics 2013; 14:319; PMID:23663360; http://dx.doi.org/10.1186/1471-2164-14-319
32. J.Baran-Gale, C.L.Kurtz, M.R.Erdos, C.Sison, A.Young, E.E.Fannin, P.S.Chines, P.Sethupathy. Addressing bias in small RNA library preparation for sequencing:A new protocol recovers MicroRNAs that evade capture by current methods. Front Genetics 2015; 6:352; PMID:26734062; http://dx.doi.org/10.3389/fgene.2015.00352
33. P.Mestdagh, N.Hartmann, L.Baeriswyl, D.Andreasen, N.Bernard, C.Chen, D.Cheo, P.D'Andrade, M.DeMayo, L.Dennis, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods 2014; 11:809-15; PMID:24973947; http://dx.doi.org/10.1038/nmeth.3014
34. M.D.Locati, I.Terpstra, W.C.de Leeuw, M.Kuzak, H.Rauwerda, W.A.Ensink, S.van Leeuwen, U.Nehrdich, H.P.Spaink, M.J.Jonker, et al. Improving small RNA-seq by using a synthetic spike-in set for size-range quality control together with a set for data normalization. Nucleic Acids Res 2015; 43:e89; PMID:25870415; http://dx.doi.org/10.1093/nar/gkv303
35. P.S.Mitchell, R.K.Parkin, E.M.Kroh, B.R.Fritz, S.K.Wyman, E.L.Pogosova-Agadjanyan, A.Peterson, J.Noteboom, K.C.O'Briant, A.Allen, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105:10513-8; PMID:18663219; http://dx.doi.org/10.1073/pnas.0804549105
36. D.C.Corney, A.Flesken-Nikitin, A.K.Godwin, W.Wang, A.Y.Nikitin. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007; 67:8433-8; PMID:17823410; http://dx.doi.org/10.1158/0008-5472.CAN-07-1585
37. H.J.Peltier, G.J.Latham. Normalization of microRNA expression levels in quantitative RT-PCR assays:identification of suitable reference RNA targets in normal and cancerous human solid tissues. Rna 2008; 14:844-52; PMID:18375788; http://dx.doi.org/10.1261/rna.939908
38. A.Popov, A.Szabo, V.Mandys. Small nucleolar RNA U91 is a new internal control for accurate microRNAs quantification in pancreatic cancer. BMC Cancer 2015; 15:774; PMID:26499892; http://dx.doi.org/10.1186/s12885-015-1785-9
39. H.Schwarzenbach, A.M.da Silva, G.Calin, K.Pantel. Data normalization strategies for microRNA quantification. Clin Chem 2015; 61:1333-42; PMID:26408530; http://dx.doi.org/10.1373/clinchem.2015.239459
40. K.Wang, Y.Yuan, J.H.Cho, S.McClarty, D.Baxter, D.J.Galas. Comparing the microRNA spectrum between serum and plasma. PLoS One 2012; 7:e41561; PMID:22859996; http://dx.doi.org/10.1371/journal.pone.0041561
41. H.H.Cheng, H.S.Yi, Y.Kim, E.M.Kroh, J.W.Chien, K.D.Eaton, M.T.Goodman, J.F.Tait, M.Tewari, C.C.Pritchard. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One 2013; 8:e64795; PMID:23762257; http://dx.doi.org/10.1371/journal.pone.0064795
42. V.S.Nair, C.C.Pritchard, M.Tewari, J.P.Ioannidis. Design and analysis for studying microRNAs in human disease:A primer on -Omic technologies. Am J Epidemiol 2014; 180:140-52; PMID:24966218; http://dx.doi.org/10.1093/aje/kwu135
43. W.Allen-Rhoades, L.Kurenbekova, L.Satterfield, N.Parikh, D.Fuja, R.L.Shuck, N.Rainusso, M.Trucco, D.A.Barkauskas, E.Jo, et al. Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma. Cancer Med 2015; 4:977-88; PMID:25784290; http://dx.doi.org/10.1002/cam4.438
44. J.Y.Krzeszinski, W.Wei, H.Huynh, Z.Jin, X.Wang, T.C.Chang, X.J.Xie, L.He, L.S.Mangala, G.Lopez-Berestein, et al. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. Nature 2014; 512:431-5; PMID:25043055; http://dx.doi.org/10.1038/nature13375
45. J.Ribas, X.Ni, M.Haffner, E.A.Wentzel, A.H.Salmasi, W.H.Chowdhury, T.A.Kudrolli, S.Yegnasubramanian, J.Luo, R.Rodriguez, et al. miR-21:an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res 2009; 69:7165-9; PMID:19738047; http://dx.doi.org/10.1158/0008-5472.CAN-09-1448
46. E.van Rooij, L.B.Sutherland, J.E.Thatcher, J.M.DiMaio, R.H.Naseem, W.S.Marshall, J.A.Hill, E.N.Olson. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008; 105:13027-32; PMID:18723672; http://dx.doi.org/10.1073/pnas.0805038105
47. K.T.Kuppusamy, D.C.Jones, H.Sperber, A.Madan, K.A.Fischer, M.L.Rodriguez, L.Pabon, W.Z.Zhu, N.L.Tulloch, X.Yang, et al. Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes. Proc Natl Acad Sci U S A 2015; 112:E2785-94; PMID:25964336; http://dx.doi.org/10.1073/pnas.1424042112
48. W.T.Wang, Y.N.Zhao, B.W.Han, S.J.Hong, Y.Q.Chen. Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis. J Clin Endocrinol Metab 2013; 98:281-9; PMID:23118427; http://dx.doi.org/10.1210/jc.2012-2415
49. J.R.Chang, R.Mukerjee, A.Bagashev, L.Del Valle, T.Chabrashvili, B.J.Hawkins, J.J.He, B.E.Sawaya. HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs. J Biol Chem 2011; 286:41125-34; PMID:21956116; http://dx.doi.org/10.1074/jbc.M111.268466
50. R.Mukerjee, J.R.Chang, L.Del Valle, A.Bagashev, M.M.Gayed, R.B.Lyde, B.J.Hawkins, E.Brailoiu, E.Cohen, C.Power, et al. Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. J Biol Chem 2011; 286:34976-85; PMID:21816823; http://dx.doi.org/10.1074/jbc.M111.241547
51. G.Mullokandov, A.Baccarini, A.Ruzo, A.D.Jayaprakash, N.Tung, B.Israelow, M.J.Evans, R.Sachidanandam, B.D.Brown. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat Methods 2012; 9:840-6; PMID:22751203; http://dx.doi.org/10.1038/nmeth.2078
52. H.Y.Jin, A.Gonzalez-Martin, A.V.Miletic, M.Lai, S.Knight, M.Sabouri-Ghomi, S.R.Head, M.S.Macauley, R.C.Rickert, C.Xiao. Transfection of microRNA mimics should be used with caution. Front Genetics 2015; 6:340; PMID:26697058; http://dx.doi.org/10.3389/fgene.2015.00340
53. D.W.Thomson, C.P.Bracken, J.M.Szubert, G.J.Goodall. On measuring miRNAs after transient transfection of mimics or antisense inhibitors. PLoS One 2013; 8:e55214; PMID:23358900; http://dx.doi.org/10.1371/journal.pone.0055214
54. M.A.Goldgraben, R.Russell, O.M.Rueda, C.Caldas, A.Git. Double-stranded microRNA mimics can induce length- and passenger strand-dependent effects in a cell type-specific manner. RNA 2016; 22:193-203; PMID:26670622; http://dx.doi.org/10.1261/rna.054072.115
55. H.Valadi, K.Ekstrom, A.Bossios, M.Sjostrand, J.J.Lee, J.O.Lotvall. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654-9; PMID:17486113; http://dx.doi.org/10.1038/ncb1596
56. S.Das, M.K.Halushka. Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc Pathol 2015; 24:199-206; PMID:25958013; http://dx.doi.org/10.1016/j.carpath.2015.04.007
57. J.P.Tosar, F.Gambaro, J.Sanguinetti, B.Bonilla, K.W.Witwer, A.Cayota. Assessment of small RNA sorting into different extracellular fractions revealed by high-throughput sequencing of breast cell lines. Nucleic Acids Res 2015; 43:5601-16; PMID:25940616; http://dx.doi.org/10.1093/nar/gkv432
58. T.Janas, M.M.Janas, K.Sapon, T.Janas. Mechanisms of RNA loading into exosomes. FEBS Letters 2015; 589:1391-8; PMID:25937124; http://dx.doi.org/10.1016/j.febslet.2015.04.036
59. J.R.Chevillet, Q.Kang, I.K.Ruf, H.A.Briggs, L.N.Vojtech, S.M.Hughes, H.H.Cheng, J.D.Arroyo, E.K.Meredith, E.N.Gallichotte, et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci U S A 2014; 111:14888-93; PMID:25267620; http://dx.doi.org/10.1073/pnas.1408301111
60. E.D.Sverdlov. Amedeo Avogadro's cry:what is 1 microg of exosomes? BioEssays 2012; 34:873-5; PMID:22815202; http://dx.doi.org/10.1002/bies.201200045
61. E.Bianconi, A.Piovesan, F.Facchin, A.Beraudi, R.Casadei, F.Frabetti, L.Vitale, M.C.Pelleri, S.Tassani, F.Piva, et al. An estimation of the number of cells in the human body. Annals Hum Biol 2013; 40:463-71; PMID:23829164; http://dx.doi.org/10.3109/03014460.2013.807878
62. R.Sender, S.Fuchs, R.Milo. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 2016; 164:337-40; PMID:26824647; http://dx.doi.org/10.1016/j.cell.2016.01.013
63. H.M.van Dongen, N.Masoumi, K.W.Witwer, D.M.Pegtel. Extracellular vesicles exploit viral entry routes for cargo delivery. Microbiol Mol Biol Rev 2016; 80:369-86; PMID:26935137; http://dx.doi.org/10.1128/MMBR.00063-15
64. M.Tkach, C.Thery. Communication by extracellular vesicles:Where we are and where we need to go. Cell 2016; 164:1226-32; PMID:26967288; http://dx.doi.org/10.1016/j.cell.2016.01.043
65. V.K.Mayya, T.F.Duchaine. On the availability of microRNA-induced silencing complexes, saturation of microRNA-binding sites and stoichiometry. Nucleic Acids Res 2015; 43:7556-65; PMID:26227970; http://dx.doi.org/10.1093/nar/gkv720
66. H.Seitz. Redefining microRNA targets. Curr Biol 2009; 19:870-3; PMID:19375315; http://dx.doi.org/10.1016/j.cub.2009.03.059
67. L.Salmena, L.Poliseno, Y.Tay, L.Kats, P.P.Pandolfi. A ceRNA hypothesis:the Rosetta Stone of a hidden RNA language? Cell 2011; 146:353-8; PMID:21802130; http://dx.doi.org/10.1016/j.cell.2011.07.014
68. A.Helwak, G.Kudla, T.Dudnakova, D.Tollervey. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 2013; 153:654-65; PMID:23622248; http://dx.doi.org/10.1016/j.cell.2013.03.043
69. R.Denzler, V.Agarwal, J.Stefano, D.P.Bartel, M.Stoffel. Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol Cell 2014; 54:766-76; PMID:24793693; http://dx.doi.org/10.1016/j.molcel.2014.03.045
70. A.Helwak, D.Tollervey. Mapping the miRNA interactome by cross-linking ligation and sequencing of hybrids (CLASH). Nature Protocols 2014; 9:711-28; PMID:24577361; http://dx.doi.org/10.1038/nprot.2014.043
71. T.M.Franks, J.Lykke-Andersen. The control of mRNA decapping and P-body formation. Mol Cell 2008; 32:605-15; PMID:19061636; http://dx.doi.org/10.1016/j.molcel.2008.11.001
72. G.Schratt. microRNAs at the synapse. Nat Rev Neurosci 2009; 10:842-9; PMID:19888283; http://dx.doi.org/10.1038/nrn2763
73. S.H.Olejniczak, G.La Rocca, J.J.Gruber, C.B.Thompson. Long-lived microRNA-Argonaute complexes in quiescent cells can be activated to regulate mitogenic responses. Proc Natl Acad Sci U S A 2013; 110:157-62; PMID:23248281; http://dx.doi.org/10.1073/pnas.1219958110
74. G.La Rocca, S.H.Olejniczak, A.J.Gonzalez, D.Briskin, J.A.Vidigal, L.Spraggon, R.G.DeMatteo, M.R.Radler, T.Lindsten, A.Ventura, et al. In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA. Proc Natl Acad Sci U S A 2015; 112:767-72; PMID:25568082; http://dx.doi.org/10.1073/pnas.1424217112
75. B.John, A.J.Enright, A.Aravin, T.Tuschl, C.Sander, D.S.Marks. Human MicroRNA targets. PLoS Biol 2004; 2:e363; PMID:15502875; http://dx.doi.org/10.1371/journal.pbio.0020363
76. V.Agarwal, G.W.Bell, J.W.Nam, D.P.Bartel. Predicting effective microRNA target sites in mammalian mRNAs. Elife 2015; 4:e05005; PMID:26267216; http://dx.doi.org/10.7554/eLife.05005
77. P.Loher, I.Rigoutsos. Interactive exploration of RNA22 microRNA target predictions. Bioinformatics 2012; 28:3322-3; PMID:23074262; http://dx.doi.org/10.1093/bioinformatics/bts615
78. J.Kruger, M.Rehmsmeier. RNAhybrid:microRNA target prediction easy, fast and flexible. Nucleic Acids Res 2006; 34:W451-4; PMID:16845047; http://dx.doi.org/10.1093/nar/gkl243
79. W.Ritchie, S.Flamant, J.E.Rasko. Predicting microRNA targets and functions:traps for the unwary. Nat Methods 2009; 6:397-8; PMID:19478799; http://dx.doi.org/10.1038/nmeth0609-397
80. Y.J.Lee, V.Kim, D.C.Muth, K.W.Witwer. Validated MicroRNA target databases:An evaluation. Drug Dev Res 2015; 76:389-96; PMID:26286669; http://dx.doi.org/10.1002/ddr.21278
81. I.S.Vlachos, M.D.Paraskevopoulou, D.Karagkouni, G.Georgakilas, T.Vergoulis, I.Kanellos, I.L.Anastasopoulos, S.Maniou, K.Karathanou, D.Kalfakakou, et al. DIANA-TarBase v7.0:indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucleic Acids Res 2015; 43:D153-9; PMID:25416803; http://dx.doi.org/10.1093/nar/gku1215
82. J.Huang, F.Wang, E.Argyris, K.Chen, Z.Liang, H.Tian, W.Huang, K.Squires, G.Verlinghieri, H.Zhang. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 2007; 13:1241-7; PMID:17906637; http://dx.doi.org/10.1038/nm1639
83. C.K.Mantri, J.Pandhare Dash, J.V.Mantri, C.C.Dash. Cocaine enhances HIV-1 replication in CD4+ T cells by down-regulating MiR-125b. PLoS One 2012; 7:e51387; PMID:23251514; http://dx.doi.org/10.1371/journal.pone.0051387
84. C.L.Andersen, J.L.Jensen, T.F.Orntoft. Normalization of real-time quantitative reverse transcription-PCR data:a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004; 64:5245-50; PMID:15289330; http://dx.doi.org/10.1158/0008-5472.CAN-04-0496
85. A.R.Chin, M.Y.Fong, G.Somlo, J.Wu, P.Swiderski, X.Wu, S.E.Wang. Cross-kingdom inhibition of breast cancer growth by plant miR159. Cell Res 2016; 26:217-28; PMID:26794868; http://dx.doi.org/10.1038/cr.2016.13
86. L.Timmons, A.Fire. Specific interference by ingested dsRNA. Nature 1998; 395:854; PMID:9804418; http://dx.doi.org/10.1038/27579
87. W.M.Winston, M.Sutherlin, A.J.Wright, E.H.Feinberg, C.P.Hunter. Caenorhabditis elegans SID-2 is required for environmental RNA interference. Proc Natl Acad Sci U S A 2007; 104:10565-70; PMID:17563372; http://dx.doi.org/10.1073/pnas.0611282104
88. E.H.Feinberg, C.P.Hunter. Transport of dsRNA into cells by the transmembrane protein SID-1. Science 2003; 301:1545-7; PMID:12970568; http://dx.doi.org/10.1126/science.1087117
89. K.W.Witwer, K.D.Hirschi. Transfer and functional consequences of dietary microRNAs in vertebrates:concepts in search of corroboration:negative results challenge the hypothesis that dietary xenomiRs cross the gut and regulate genes in ingesting vertebrates, but important questions persist. BioEssays 2014; 36:394-406; PMID:24436255; http://dx.doi.org/10.1002/bies.201300150
90. J.Pak, A.Fire. Distinct populations of primary and secondary effectors during RNAi in C. elegans. Science 2007; 315:241-4; PMID:17124291; http://dx.doi.org/10.1126/science.1132839
91. L.Zhang, D.Hou, X.Chen, D.Li, L.Zhu, Y.Zhang, J.Li, Z.Bian, X.Liang, X.Cai, et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1:evidence of cross-kingdom regulation by microRNA. Cell Res 2012; 22:107-26; PMID:21931358; http://dx.doi.org/10.1038/cr.2011.158
92. Y.Zhang, B.E.Wiggins, C.Lawrence, J.Petrick, S.Ivashuta, G.Heck. Analysis of plant-derived miRNAs in animal small RNA data sets. BMC Genomics 2012; 13:381; PMID:22873950; http://dx.doi.org/10.1186/1471-2164-13-381
93. J.P.Tosar, C.Rovira, H.Naya, A.Cayota. Mining of public sequencing databases supports a non-dietary origin for putative foreign miRNAs:underestimated effects of contamination in NGS. RNA 2014; 20:754-7; PMID:24729469; http://dx.doi.org/10.1261/rna.044263.114
94. K.W.Witwer. XenomiRs and miRNA homeostasis in health and disease:evidence that diet and dietary miRNAs directly and indirectly influence circulating miRNA profiles. RNA Biol 2012; 9:1147-54; PMID:22951590; http://dx.doi.org/10.4161/rna.21619
95. B.Dickinson, Y.Zhang, J.S.Petrick, G.Heck, S.Ivashuta, W.S.Marshall. Lack of detectable oral bioavailability of plant microRNAs after feeding in mice. Nat Biotechnol 2013; 31:965-7; PMID:24213763; http://dx.doi.org/10.1038/nbt.2737
96. J.W.Snow, A.E.Hale, S.K.Isaacs, A.L.Baggish, S.Y.Chan. Ineffective delivery of diet-derived microRNAs to recipient animal organisms. RNA Biol 2013; 10:1107-16; PMID:23669076; http://dx.doi.org/10.4161/rna.24909
97. K.W.Witwer, M.A.McAlexander, S.E.Queen, R.J.Adams. Real-time quantitative PCR and droplet digital PCR for plant miRNAs in mammalian blood provide little evidence for general uptake of dietary miRNAs:limited evidence for general uptake of dietary plant xenomiRs. RNA Biol 2013; 10:1080-6; PMID:23770773; http://dx.doi.org/10.4161/rna.25246
98. Receptive to replication. Nat Biotechnol 2013; 31:943; PMID:24213747; http://dx.doi.org/10.1038/nbt.2748
99. H.Liang, S.Zhang, Z.Fu, Y.Wang, N.Wang, Y.Liu, C.Zhao, J.Wu, Y.Hu, J.Zhang, et al. Effective detection and quantification of dietetically absorbed plant microRNAs in human plasma. J Nutri Biochem 2015; 26:505-12; PMID:25704478; http://dx.doi.org/10.1016/j.jnutbio.2014.12.002
100. K.W.Witwer. Contamination or artifacts may explain reports of plant miRNAs in humans. J Nutri Biochem 2015; 26:1685; PMID:26456566; http://dx.doi.org/10.1016/j.jnutbio.2015.09.004
101. J.Laubier, J.Castille, S.Le Guillou, F.Le Provost. No effect of an elevated miR-30b level in mouse milk on its level in pup tissues. RNA Biol 2015; 12:26-9; PMID:25763824; http://dx.doi.org/10.1080/15476286.2015.1017212
102. A.C.Title, R.Denzler, M.Stoffel. Uptake and function studies of maternal Milk-derived MicroRNAs. J Biol Chem 2015; 290:23680-91; PMID:26240150; http://dx.doi.org/10.1074/jbc.M115.676734
103. S.R.Baier, C.Nguyen, F.Xie, J.R.Wood, J.Zempleni. MicroRNAs are absorbed in biologically meaningful amounts from nutritionally relevant doses of cow milk and affect gene expression in peripheral blood mononuclear cells, HEK-293 kidney cell cultures, and mouse livers. J Nutri 2014; 144:1495-500; PMID:25122645; http://dx.doi.org/10.3945/jn.114.196436
104. A.Auerbach, G.Vyas, A.Li, M.Halushka, K.W.Witwer. Uptake of dietary milk miRNAs by adult humans:a validation study. F1000 Res 2016; 5:721; PMID:27158459; http://dx.doi.org/10.12688/f1000research.8548.1
105. S.F.Tavazoie, C.Alarcon, T.Oskarsson, D.Padua, Q.Wang, P.D.Bos, W.L.Gerald, J.Massague. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451:147-52; PMID:18185580; http://dx.doi.org/10.1038/nature06487
106. J.J.McCarthy. MicroRNA-206:the skeletal muscle-specific myomiR. Biochim Et Biophys Acta 2008; 1779:682-91; PMID:18381085; http://dx.doi.org/10.1016/j.bbagrm.2008.03.001
107. J.Zhang, Y.Y.Du, Y.F.Lin, Y.T.Chen, L.Yang, H.J.Wang, D.Ma. The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun 2008; 377:136-40; PMID:18834857; http://dx.doi.org/10.1016/j.bbrc.2008.09.089
108. J.Y.Huang, K.Zhang, D.Q.Chen, J.Chen, B.Feng, H.Song, Y.Chen, Z.Zhu, L.Lu, W.De, et al. MicroRNA-451:epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Oncotarget 2015; 6:18613-30; PMID:26164082; http://dx.doi.org/10.18632/oncotarget.4317
109. H.P.Li, X.C.Zeng, B.Zhang, J.T.Long, B.Zhou, G.S.Tan, W.X.Zeng, W.Chen, J.Y.Yang. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β. Carcinogenesis 2013; 34:2443-51; PMID:23740840; http://dx.doi.org/10.1093/carcin/bgt206
110. W.Q.Zang, X.Yang, T.Wang, Y.Y.Wang, Y.W.Du, X.N.Chen, M.Li, G.Q.Zhao. MiR-451 inhibits proliferation of esophageal carcinoma cell line EC9706 by targeting CDKN2D and MAP3K1. World J Gastroenterol 2015; 21:5867-76; PMID:26019450
111. Z.Li, S.Wu, S.Lv, H.Wang, Y.Wang, Q.Guo. Suppression of liver receptor homolog-1 by microRNA-451 represses the proliferation of osteosarcoma cells. Biochem Biophys Res Commun 2015; 461:450-5; PMID:25869073; http://dx.doi.org/10.1016/j.bbrc.2015.04.013
112. F.Zhang, W.Huang, M.Sheng, T.Liu. MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients. Tumour Biol 2015; 36:2041-8; PMID:25391425; http://dx.doi.org/10.1007/s13277-014-2811-2
113. Y.Kuwabara, T.Horie, O.Baba, S.Watanabe, M.Nishiga, S.Usami, M.Izuhara, T.Nakao, T.Nishino, K.Otsu, et al. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway. Circ Res 2015; 116:279-88; PMID:25362209; http://dx.doi.org/10.1161/CIRCRESAHA.116.304707
114. P.Yin, R.Peng, H.Peng, L.Yao, Y.Sun, L.Wen, T.Wu, J.Zhou, Z.Zhang. MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells. Mol Biotechnol 2015; 57:1-11; PMID:25150396; http://dx.doi.org/10.1007/s12033-014-9796-3
115. J.S.Grant, I.Morecroft, Y.Dempsie, E.van Rooij, M.R.MacLean, A.H.Baker. Transient but not genetic loss of miR-451 is protective in the development of pulmonary arterial hypertension. Pulmonary Circulation 2013; 3:840-50; PMID:25006399; http://dx.doi.org/10.1086/674751
116. D.Liu, C.Liu, X.Wang, S.Ingvarsson, H.Chen. MicroRNA-451 suppresses tumor cell growth by down-regulating IL6R gene expression. Cancer Epidemiol 2014; 38:85-92; PMID:24445140; http://dx.doi.org/10.1016/j.canep.2013.12.005
117. H.Y.Li, Y.Zhang, J.H.Cai, H.L.Bian. MicroRNA-451 inhibits growth of human colorectal carcinoma cells via downregulation of Pi3k/Akt pathway. Asian Pacific J Cancer Prevention 2013; 14:3631-4; PMID:23886157; http://dx.doi.org/10.7314/APJCP.2013.14.6.3631
118. F.Liu, J.Wang, Q.Fu, X.Zhang, Y.Wang, J.Liu, J.Huang, X.Lv. VEGF-activated miR-144 regulates autophagic survival of prostate cancer cells against Cisplatin. Tumour Biol 2015; PMID:26566625; http://dx.doi.org/10.1007/s13277-015-4383-1
119. H.L.Pan, Z.S.Wen, Y.C.Huang, X.Cheng, G.Z.Wang, Y.C.Zhou, Z.Y.Wang, Y.Q.Guo, Y.Cao, G.B.Zhou. Down-regulation of microRNA-144 in air pollution-related lung cancer. Scientific Reports 2015; 5:14331; PMID:26395400; http://dx.doi.org/10.1038/srep14331
120. F.Gao, T.Wang, Z.Zhang, R.Wang, Y.Guo, J.Liu. Regulation of activating protein-4-associated metastases of non-small cell lung cancer cells by miR-144. Tumour Biol 2015; PMID:26254097; http://dx.doi.org/10.1007/s13277-015-3866-4
121. F.Lan, H.Yu, M.Hu, T.Xia, X.Yue. miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met. J Neurochem 2015; 135:274-86; PMID:26250785; http://dx.doi.org/10.1111/jnc.13272
122. R.Matsushita, N.Seki, T.Chiyomaru, S.Inoguchi, T.Ishihara, Y.Goto, R.Nishikawa, H.Mataki, S.Tatarano, T.Itesako, et al. Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer. Br J Cancer 2015; 113:282-9; PMID:26057453; http://dx.doi.org/10.1038/bjc.2015.195
123. W.Wang, X.Zhou, M.Wei. MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2. Oncotarget 2015; 6:10297-308; PMID:25912304; http://dx.doi.org/10.18632/oncotarget.3305
124. L.Lin, Y.Zheng, Y.Tu, Z.Wang, H.Liu, X.Lu, L.Xu, J.Yuan. MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2. Hum Pathol 2015; 46:971-80; PMID:25907866; http://dx.doi.org/10.1016/j.humpath.2015.01.023
125. S.Chen, P.Li, J.Li, Y.Wang, Y.Du, X.Chen, W.Zang, H.Wang, H.Chu, G.Zhao, et al. MiR-144 inhibits proliferation and induces apoptosis and autophagy in lung cancer cells by targeting TIGAR. Cell Physiol Biochem 2015; 35:997-1007; PMID:25660220; http://dx.doi.org/10.1159/000369755